TrialBritish journal of clinical pharmacology2003

Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.

Rocco Orlando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.